Haemonetics Corporation (HAE) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $62.21
• Market Cap: $2.92B
• P/E Ratio: 17.17
• EPS: $3.63
• 52-Week High: $87.32
• 52-Week Low: $47.32

Market Sentiment

Haemonetics Corporation currently has a Bullish sentiment score of 0.42.

About Haemonetics Corporation

Haemonetics Corporation is a leading global healthcare company headquartered in Boston, Massachusetts, specializing in innovative medical products and solutions for blood and plasma collection, as well as surgical procedures. The company harnesses advanced technology to improve the quality and efficiency of healthcare delivery, addressing critical patient care needs through its diverse product portfolio. Committed to enhancing patient outcomes worldwide, Haemonetics is actively expanding its ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Haemonetics Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does HAE pay dividends?

Haemonetics Corporation (HAE) does not currently pay a regular dividend.

What is HAE's P/E ratio?

Haemonetics Corporation has a price-to-earnings (P/E) ratio of 17.17.

What is HAE's market cap?

Haemonetics Corporation (HAE) has a market capitalization of $2.92B with a current stock price of $62.21.